| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | MASS 908 Devices Inc. | McCallion Kevin J. | SVP, Products And Production | Sell | 24,000 | $7.05 | $169,091.60 | -21.1% | - | - | |
| Apr 8, 2026 | DXR Daxor Corporation | Feldschuh Michael Richard75 | Chief Executive Officer | Buy | 1,000 | $9.07 | $9,070.00 | +0.5% | - | - | |
| Apr 7, 2026 | RSMDF Resmed Inc. | Farrell Michael J.62 | Chairman And CEO | Sell | 4,991 | $225.50 | $1,125,486.47 | -1.1% | - | - | |
| Apr 7, 2026 | IRMD Iradimed Corporation | Susi Roger E.53 | CEO, President, Chairman | Sell | 7,500 | $95.63 | $717,207.59 | - | - | - | |
| Apr 6, 2026 | CBLL Ceribell, Inc. | Chao Xingjuan57 | President And CEO | Sell | 39,000 | $18.40 | $717,600.00 | -1.5% | - | - | |
| Apr 6, 2026 | SGHT Sight Sciences, Inc. | Rodberg James62 | Chief Financial Officer | Sell | 7,231 | $3.55 | $25,670.05 | -3.0% | - | - | |
| Apr 6, 2026 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.63 | Chief Legal Officer | Sell | 13,761 | $3.55 | $48,851.55 | -3.6% | - | - | |
| Apr 6, 2026 | EW Edwards Lifesciences Corporation | Lippis Daniel J.62 | Cvp, Tavr | Sell | 1,019 | $80.98 | $82,522.70 | -2.9% | - | - | |
| Apr 2, 2026 | PEN Penumbra, Inc. | Grewal Harpreet60 | Director | Sell | 100 | $328.22 | $32,822.00 | -1.1% | - | - | |
| Apr 1, 2026 | TIVC Tivic Health Systems, Inc. | Valauri Christina Rizopoulos | Director | Buy | 19,000 | $0.95 | $18,008.20 | New | - | - | |
| Apr 1, 2026 | RSMDF Resmed Inc. | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $224.31 | $224,310.00 | -1.2% | - | - | |
| Mar 31, 2026 | DXR Daxor Corporation | Michel Robert J61 | Chief Financial Officer | Buy | 1,000 | $9.90 | $9,900.00 | +5.0% | - | - | |
| Mar 31, 2026 | VVOS Vivos Therapeutics, Inc. | Skaff Michael C | 10% Owner | Buy | 1,353,625 | $1.34 | $1,813,857.50 | +129.6% | - | - | |
| Mar 30, 2026 | IRMD Iradimed Corporation | Susi Roger E.53 | CEO, President, Chairman | Sell | 7,500 | $95.02 | $712,614.05 | -0.1% | - | - | |
| Mar 27, 2026 | STIM Neuronetics, Inc. | Chernett Jorey | 10% Owner | Buy | 500,000 | $1.35 | $675,000.00 | +5.6% | - | - | |
| Mar 26, 2026 | BDX Becton, Dickinson And Company | Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $156.83 | $11,762.25 | -0.4% | - | - | |
| Mar 26, 2026 | VERO Venus Concept Inc. | Madryn Asset Management, LP | 10% Owner | Buy | 37,537,187 | $0.04 | $1,500,000.00 | +100.0% | - | - | |
| Mar 26, 2026 | STIM Neuronetics, Inc. | Chernett Jorey | 10% Owner | Buy | 150,000 | $1.41 | $211,000.00 | +0.9% | - | - | |
| Mar 25, 2026 | GKOS Glaukos Corporation | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 2,511 | $106.46 | $267,321.06 | -5.6% | - | - | |
| Mar 25, 2026 | ESTA Establishment Labs Holdings Inc. | Chacon Quiros Juan Jose48 | Director | Sell | 3,575 | $60.08 | $214,768.13 | -0.3% | - | - | |
| Mar 24, 2026 | GKOS Glaukos Corporation | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 1,521 | $105.24 | $160,070.04 | -3.2% | - | - | |
| Mar 23, 2026 | BLFS Biolife Solutions, Inc. | Foster Karen A.68 | Chief Quality And Operations | Sell | 2,577 | $19.17 | $49,401.09 | -2.3% | - | - | |
| Mar 23, 2026 | ESTA Establishment Labs Holdings Inc. | Chacon Quiros Juan Jose48 | Director | Sell | 33,925 | $60.39 | $2,048,696.98 | -0.7% | - | - | |
| Mar 20, 2026 | STIM Neuronetics, Inc. | Chernett Jorey | 10% Owner | Buy | 169,472 | $1.41 | $238,955.52 | +2.0% | - | - | |
| Mar 20, 2026 | OSUR Orasure Technologies, Inc. | McGrath Kenneth J | Chief Financial Officer | Buy | 32,300 | $2.93 | $94,600.24 | +5.8% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.